HomeNewsBusinessRatan Tata questions ‘definition of ethics’ of companies that lay off long-serving employees

Ratan Tata questions ‘definition of ethics’ of companies that lay off long-serving employees

Chairman of Tata Trusts, Ratan Tata said that the way of doing business has to change and laying-off employees is not the solution.

July 24, 2020 / 12:12 IST
Story continues below Advertisement

Chairman of Tata Trusts, Ratan Tata on July 23 said sensitivity towards employees is crucial to survive and do well in the long run. Layoffs amid the COVID-19 pandemic was a knee-jerk reaction and shows lack of empathy among the top leadership, Tata said.

The nationwide lockdowns have impacted businesses across sectors. Several have resorted to layoffs and salary cuts to trim costs.

Story continues below Advertisement

"These are the people that have worked for you, these are the people who have served you all their careers so you send them out to live in the rain? Is that your definition of ethics when you treat your labour force that way?" Tata quipped.

Track this blog for LIVE updates on coronavirus pandemic

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show